Search
for
Sort by
Research 91–120 of 1000+
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- A systematic review and meta-analysis on the association between androgenic alopecia and the risk of metabolic syndrome
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- The diagnosis of polycystic ovary syndrome in adolescents
- Testosterone therapy for transgender men
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- What causes hidradenitis suppurativa ?—15 years after
- STEROIDS AND STEROID-LIKE COMPOUNDS
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Transgender health and the impact of aging and menopause
- Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies
- Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
- Clinical characteristics in Taiwanese women with polycystic ovary syndrome
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Women’s Health Considerations for Lipid Management
- Polycystic ovary syndrome
- Management of transgender patients in critical care
- What does the research say about androgen use and cerebrovascular events?
- Metformin or thiazolidinedione therapy in PCOS?
- Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice
- Influence of The Anabolic Steroid Usage on The Physical Health: A Review
- The Role of the Athletic Trainer in Providing Care to Transgender and Gender-Diverse Patients: Considerations for Medical Affirmation—Part II
- Early Androgenetic Alopecia as a Metabolic Signal, Not Yet a Diabetes Predictor
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- A STUDY OF EFFICACY AND SAFETY OF ORAL MINOXIDIL IN MALE ANDROGENETIC ALOPECIA